Implications of the Lapse in Federal COVID-19 Funding on Access to COVID-19 Testing, Treatment, and Vaccines
A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.
This analysis examines the cost of COVID-19 treatment for inpatient care among people with health coverage through large employers. It finds that in 2020, COVID-19 hospitalizations cost an average of $41,611, including an average out-of-pocket payment of $1,280 for people with large employer coverage.
This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. Under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies.
Update on Children’s COVID-19 and Routine Vaccination Trends Heading into Winter and as Respiratory Viruses Surge
This policy watch describes recent trends in children’s COVID-19 and routine vaccinations and explores strategies to increase vaccination rates among children as we head into the winter season.
Over the course of the pandemic, racial disparities in cases and deaths have widened and narrowed. However, overall, Black, Hispanic, and American Indian and Alaska Native (AIAN) people have borne the heaviest health impacts of the pandemic. While Black and Hispanic people were less likely than their White counterparts to receive a vaccine during the initial phases of the vaccination rollout, these disparities have narrowed over time and reversed for Hispanic people.
Community Health Centers Are A Key Source of COVID-19 Rapid At-Home Self-Tests For Hard-To-Reach GroupsAs part of an effort to promote equitable access to tests, 25 million rapid at-home self-test kits were to be distributed by community health centers with a focus on reaching populations at greatest risk from adverse outcomes related to COVID-19.
There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S. Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.
- Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.